查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1983869

靜脈注射裝置市場：按產品類型、材質、便攜性、應用和最終用戶分類的全球市場預測 – 2026-2032 年

Intravenous Equipment Market by Product Type, Material Type, Portability, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，靜脈注射設備市場價值將達到 140.7 億美元，到 2026 年將成長至 149.6 億美元，到 2032 年將達到 215.9 億美元，複合年成長率為 6.30%。

主要市場統計數據
基準年 2025 140.7億美元
預計年份：2026年 149.6億美元
預測年份 2032 215.9億美元
複合年成長率 (%) 6.30%

全面概述了正在重塑所有醫療保健機構靜脈輸液治療的臨床需求、供應鏈現狀和技術進步。

靜脈注射裝置領域處於臨床需求與技術可能性的交匯點，受到不斷變化的醫療保健格局、日益提高的感染控制要求以及對以患者為中心的護理模式的需求的深刻影響。臨床醫生依賴各種裝置和耗材來安全有效地輸注液體、藥物和營養，而耐用輸液泵與一次性配件之間的配合仍然是日常實踐的核心。隨著住院時間的縮短以及門診和居家照護的擴展，兼顧便攜性、準確性和成本效益已成為醫療服務提供者和製造商的策略重點。

智慧型設備的整合、向門診和居家照護的轉變以及對永續性的日益重視，正在重新定義靜脈注射設備的設計、採購和服務模式。

靜脈注射設備領域正經歷著一場變革，這主要得益於三大因素的交匯：技術進步、照護模式的轉變以及對監管和永續性日益成長的期望。整合安全軟體和互通性的智慧型輸液幫浦正從選購功能轉變為先進醫療環境中的必備要素，這迫使原始設備製造商 (OEM) 和醫院 IT 團隊投資於設備管理平台和雙向資料流。同時，居家輸液和門診護理的日益普及推動了對高度便攜、易於使用的設備以及專為非臨床環境設計的耗材的需求，從而再次凸顯了培訓、遠端監控和供應物流的重要性。

評估近期關稅政策對靜脈注射裝置生態系統中的籌資策略、供應商韌性、採購行為和產品生命週期經濟的持久影響。

近期政策週期中實施的貿易措施對靜脈注射器材的供應鏈策略、成本模型和採購決策產生了累積影響。關稅帶來的成本壓力迫使製造商和經銷商重新思考其全球採購結構，許多企業加快了生產回流的步伐，並對低關稅地區的二級供應商進行認證，以維持盈利能力和準時交貨的可靠性。作為應對措施，醫療機構和集團採購組織正在收緊合約條款，提高庫存可視性要求，並優先考慮能夠證明其冗餘性和短期交貨保證的供應商。

詳細的細分分析揭示了產品系列、最終用戶環境、臨床應用、一次性選項、便攜性要求和材料選擇如何決定採購和設計優先順序。

細分市場層面的趨勢揭示了不同產品系列、最終用戶、應用、一次性用品選擇、便攜性偏好和材料選擇等方面的促進因素和決策標準各不相同。在產品類型內部，諸如滴壺、延長管、過濾器和輸液器等配件的選擇通常取決於採購週期，採購週期優先考慮無菌保證、兼容性和單位成本效益；而套管的選擇（帶翼和不帶翼兩種類型）則取決於治療環境和臨床醫生的偏好。導管的選擇是基於臨床因素，中央靜脈導管、周邊靜脈導管和周邊置入的中央靜脈導管分別適用於不同的治療路徑和感染控制系統。輸液幫浦是技術權衡範圍最廣的領域。彈性體幫浦為門診輸液提供便利性和一次性使用性；胰島素幫浦需要挽救生命的精準度和符合人體工學的操作；注射式幫浦滿足精確小容量給藥的需求；而容量幫浦在高危險環境下的控制給藥中發揮核心作用。

影響製造業、監管方法和部署模式的美洲、歐洲、中東和非洲以及亞太地區的區域市場特徵和戰略重點。

區域趨勢對整個靜脈注射器材市場的製造、監管路徑和部署模式產生顯著影響。在美洲，大規模綜合醫療保健系統和健全的私人保險體系推動了對兼顧臨床療效和成本控制的解決方案的需求。該市場青睞那些能夠提供強大服務網路、相容耗材以及與電子健康記錄成熟互通性的供應商。在歐洲、中東和非洲，不同的監管環境和不斷變化的報銷機制要求企業制定個人化的打入市場策略，其中公私混合體系通常優先考慮以競標為基礎的採購方式，強調產品生命週期價值和符合當地安全標準。在亞太地區，對醫院基礎設施的快速投資、對居家醫療日益成長的關注以及充滿活力的製造業基地，使該地區成為重要的需求中心和全球生產網路的關鍵樞紐。

概述競爭格局，其中設備智慧、生命週期服務和供應鏈敏捷性的創新將決定哪些公司能夠獲得長期的商業性和臨床優勢。

靜脈注射設備產業的競爭動態取決於產品創新、服務能力和供應可靠性方面的差異化。主要企業正日益將卓越的硬體效能與支援安全性、數據分析和遠端設備管理的軟體功能相結合。售後服務和耗材仍然是維繫客戶關係的重要因素，而提供透明的生命週期成本模型、及時的技術支援和以臨床醫生為中心的培訓的供應商則能確保長期的採購優勢。策略夥伴關係、與醫療機構的共同開發契約以及對人因工程研究的投資，能夠提升產品與市場的契合度，並在細分市場中建立穩固的防禦地位。

醫療設備製造商和供應商的實用策略重點是提高設備互通性、供應彈性、永續性以及將商業性獎勵與臨床結果一致的服務模式。

產業領導企業應採取多管齊下的策略，使產品開發、商業模式和業務永續營運與不斷變化的臨床和採購需求保持一致。優先投資於互通性標準和以使用者為中心的設計，並確保輸液幫浦及其配件能夠無縫整合到電子健康記錄和臨床工作流程中，將有助於減少警報疲勞，並提高輸液通訊協定的依從性。同時，採購管道多元化和本地供應商認證將有助於降低貿易政策變化帶來的風險，並制定支援庫存可見性和快速補貨的合約條款。將完善的培訓和遠端支援功能整合到商業服務中，將增強使用者信心，尤其是在臨床監管分散的門診和居家照護環境中。

方法論的透明度描述了一種基於三角測量的調查方法，該方法整合了對臨床醫生的訪談、監管審查、技術規範分析和供應鏈場景測試。

本研究採用混合方法，結合定性相關人員訪談、技術文獻綜述、監管分析和供應鏈圖譜，並對研究結果進行三角檢驗。一級資訊來源包括與急診、門診和家庭護理機構的臨床醫生、採購經理、臨床工程師和生產主管進行的結構化訪談，以了解實際決策標準和營運限制。二級資訊來源包括醫療設備監管指南、同行評審的臨床研究和製造商的技術規範，以檢驗性能聲明和安全考慮。

全面觀點強調需要將醫療設備智慧、供應可靠性和永續實踐融入長期靜脈注射器材策略。

總之，靜脈注射裝置策略如今面臨多方面的挑戰，不僅包括裝置性能，還包括連接性、供應鏈韌性和環境因素。臨床醫生和採購經理面臨著相互衝突的優先事項：既要確保病人安全和給藥準確性，也要控制總成本和維持營運連續性。最成功的市場參與企業將是那些能夠將產品創新與切實可行的服務交付和透明的供應策略相結合的企業，從而使醫療服務提供者能夠在不損害安全性和可及性的前提下，滿足不斷發展的醫療模式的需求。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章靜脈注射裝置市場：依產品類型分類

  • 配件
    • 點滴室
    • 延長管
    • 篩選
    • 點滴器
  • 套管
    • 沒有翅膀
    • 長著翅膀
  • 導管
    • 中央靜脈
    • 外圍
    • 周邊置入的中央靜脈導管
  • 點滴幫浦
    • 彈性體泵
    • 胰島素幫浦
    • 注射式幫浦
    • 容積式泵

第9章：靜脈注射器材市場：依材料類型分類

  • 聚烯
  • 聚氨酯
  • 聚氯乙烯

第10章靜脈注射設備市場－可攜式

  • 可攜式的
  • 固定式

第11章靜脈注射裝置市場：依應用分類

  • 麻醉
  • 重症監護
  • 營養療法
  • 腫瘤學
  • 疼痛管理

第12章靜脈注射設備市場：依最終用戶分類

  • 門診治療
    • 診所
    • 診斷中心
  • 居家醫療
  • 醫院
    • 一般的
    • 專科診所

第13章靜脈注射裝置市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章靜脈注射器材市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章靜脈注射器材市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章：美國靜脈注射器材市場

第17章：中國靜脈注射器材市場

第18章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Abcam Inc.
  • Advin Health Care
  • Angel Electronic Equipment Co., Ltd.
  • Argon Medical Devices, Inc.
  • B. Braun SE
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • CODAN ARGUS AG
  • Cook Group Incorporated
  • Freudenberg Medical, LLC
  • Henry Schein, Inc.
  • ICU Medical, Inc
  • Ivenix Inc.
  • Merck KGaA
  • Novo Nordisk A/S
  • Pfizer Inc.
  • QIAGEN
  • Siemens AG
  • Smith & Nephew PLC
  • Stryker Corporation
  • Teleflex Incorporated.
  • Terumo Corporation
  • Thermo Fisher Scientific Inc.
Product Code: MRR-F6513A06BEE9

The Intravenous Equipment Market was valued at USD 14.07 billion in 2025 and is projected to grow to USD 14.96 billion in 2026, with a CAGR of 6.30%, reaching USD 21.59 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 14.07 billion
Estimated Year [2026] USD 14.96 billion
Forecast Year [2032] USD 21.59 billion
CAGR (%) 6.30%

A comprehensive orientation to the clinical imperatives, supply chain realities, and technological trajectories that are reshaping intravenous therapy delivery across care settings

The intravenous equipment arena stands at the intersection of clinical necessity and technological possibility, shaped by changing care settings, heightened infection control expectations, and accelerating demand for patient-centric delivery models. Clinicians rely on a broad array of devices and consumables to deliver fluids, medications, and nutrition safely and effectively, and the interplay between durable infusion pumps and single-use accessories remains central to daily practice. As inpatient stays shorten and outpatient and home-based care expand, the balance between portability, precision, and cost-efficiency has become a strategic priority for providers and manufacturers alike.

Beyond clinical dynamics, supply chain resilience and regulatory rigor have moved to the forefront of buyer criteria. Health systems and procurement leaders increasingly evaluate not only unit price but also lifecycle costs, service continuity, and material compliance. Simultaneously, innovation in pump intelligence, connectivity, and materials science is redefining product roadmaps and commercial conversations. This introduction frames the report's exploration of clinical trends, procurement imperatives, and product evolution, providing a foundation for actionable insights across stakeholders involved in intravenous therapy delivery.

How smart device integration, care delivery migration to outpatient and home settings, and sustainability priorities are jointly redefining intravenous equipment design, procurement, and service models

The landscape for intravenous equipment is undergoing transformative shifts driven by three converging forces: technological advancement, care model migration, and heightened regulatory and sustainability expectations. Smart infusion pumps with integrated safety software and interoperability capabilities are moving from optional enhancements to core requirements in higher acuity settings, prompting OEMs and hospital IT teams to invest in device management platforms and bidirectional data flows. At the same time, the proliferation of home infusion and ambulatory care has elevated demand for portable, user-friendly devices and single-use accessories designed for nonclinical environments, which places new emphasis on training, remote monitoring, and supply logistics.

Material innovation and environmental considerations are also driving change. Device designers and procurement teams are increasingly prioritizing alternatives to legacy materials to address concerns about plasticizers and waste management. Meanwhile, manufacturers are reconfiguring production footprints and supplier networks in response to trade policy shifts and resilience planning. Collectively, these shifts are not isolated; they create feedback loops in which clinical preferences, procurement policies, and regulatory guidance accelerate adoption of particular form factors and materials, thereby influencing OEM development priorities and aftermarket service models.

Assessing the persistent effects of recent tariff policies on sourcing strategies, supplier resilience, procurement behavior, and product lifecycle economics within the intravenous equipment ecosystem

Trade measures implemented in recent policy cycles have exerted a cumulative influence on supply chain strategies, costing models, and sourcing decisions for intravenous equipment. Tariff-driven cost pressures have compelled manufacturers and distributors to re-evaluate global sourcing mixes, with many accelerating reshoring efforts or qualifying secondary suppliers in lower-tariff jurisdictions to preserve margin and delivery reliability. Health systems and group purchasing organizations have responded by tightening contract terms, extending inventory visibility requirements, and placing a premium on suppliers that can demonstrate redundancy and near-term delivery assurances.

These dynamics also shape product roadmaps. When procurement faces elevated input costs, buyers tend to prioritize consumables with predictable pricing and durable equipment with service agreements that smooth lifecycle expenses. In addition, tariffs can influence the economics of material substitution and manufacturing automation, incentivizing investment in higher-value processes that reduce labor intensity or lower tariff exposure. Mitigation strategies adopted by market participants include strategic stockpiling, renegotiation of supply contracts, and enhanced collaboration between clinical engineering and procurement to validate clinically equivalent alternatives. Over time, such adjustments alter competitive positioning: suppliers that can transparently manage cross-border complexity and provide consistent clinical support gain relative advantage in tender processes and long-term partnerships.

In-depth segmentation analysis revealing how product families, end-user settings, clinical applications, disposability choices, portability demands, and material selections determine procurement and design priorities

Segment-level dynamics reveal distinct drivers and decision criteria across product families, end users, applications, disposability choices, portability preferences, and material selection. Within product types, accessories such as drip chambers, extension tubing, filters, and infusion sets are often governed by procurement cycles that prize sterility assurance, compatibility, and unit economics, whereas cannula choices between non-winged and winged variants hinge on procedural context and clinician preference. Catheter selection is clinically driven, with central, peripheral, and peripherally inserted central catheters each serving different care pathways and infection control regimes. Infusion pumps present the broadest range of technical trade-offs: elastomeric pumps offer simplicity and disposability for ambulatory infusion, insulin pumps demand life-critical accuracy and user ergonomics, syringe pumps address small-volume precision needs, and volumetric pumps are central to controlled delivery in higher acuity settings.

End-user context further shapes product adoption and service models. Ambulatory care settings such as clinics and diagnostic centers focus on throughput, ease of use, and disposability to minimize turnover risk, while home healthcare providers prioritize portability, patient education, and remote monitoring capabilities. Hospitals, whether general or specialty, invest in interoperability, alarm management, and preventive maintenance programs to protect patient safety and asset uptime. Application areas like anesthesia, critical care, nutrition therapy, oncology, and pain management impose distinct performance and regulatory expectations that influence purchasing decisions and vendor selection. The disposable versus reusable calculus is informed by infection control protocols, total cost of ownership analyses, and environmental policy. Portability considerations create a bifurcation between portable devices optimized for mobility and stationary systems designed for integration into clinical workflows. Material selection among polyolefin, polyurethane, and polyvinyl chloride reflects trade-offs between flexibility, chemical compatibility, biocompatibility, and regulatory scrutiny. Understanding these intersecting segmentation vectors enables manufacturers and purchasers to align product specifications with clinical workflows and procurement priorities, and to design service models that respond to the nuanced needs of each segment.

Regional market signatures and strategic priorities across the Americas, Europe Middle East and Africa, and Asia-Pacific that influence manufacturing, regulatory approach, and adoption patterns

Regional dynamics have profound implications for manufacturing, regulatory pathways, and adoption patterns across the intravenous equipment landscape. In the Americas, large integrated health systems and a robust private payer environment create demand for solutions that combine clinical performance with cost containment; this market favors suppliers that offer strong service networks, compatible consumables, and demonstrated interoperability with electronic health records. Across Europe, the Middle East, and Africa, regulatory diversity and variable reimbursement landscapes require tailored market entry strategies, and hybrid public-private systems often prioritize tender-based procurement that emphasizes total lifecycle value and compliance with regional safety standards. In the Asia-Pacific region, rapid investment in hospital infrastructure, a growing emphasis on home healthcare, and a dynamic manufacturing base position the region as both a major demand center and a critical node in global production networks.

Each region also presents distinct logistical and competitive challenges. The Americas' emphasis on documented service performance and bundled maintenance agreements raises the bar for suppliers seeking long-term contracts. Europe, the Middle East, and Africa demand nuanced regulatory navigation and an ability to serve heterogeneous clinical contexts, from high-acuity urban centers to resource-constrained facilities. Asia-Pacific's pace of technological adoption and its role in component manufacturing create opportunities for strategic partnerships, joint development, and cost-competitive sourcing, while also requiring attention to local compliance regimes and language of clinical engagement. Recognizing these regional signatures enables companies to prioritize investments and tailor value propositions to meet the expectations of clinicians, procurement teams, and regulators across diverse markets.

Competitive landscape overview where innovation in device intelligence, lifecycle services, and supply chain agility determines who captures long-term commercial and clinical advantage

Competitive dynamics within the intravenous equipment space are defined by differentiation along product innovation, service capability, and supply reliability. Leading companies increasingly combine hardware excellence with software-enabled features that support safety, analytics, and remote device management. Aftermarket services and consumables remain a durable source of customer lock-in, and providers that offer transparent lifecycle cost models, rapid technical support, and clinician-focused training secure long-term procurement advantages. Strategic partnerships, co-development arrangements with clinical institutions, and investments in human factors research bolster product-market fit and create defensible positions in specialty segments.

At the same time, competitive pressure incentivizes operational efficiency and nimble supply chain strategies. Companies that excel in supplier diversification, manufacturing flexibility, and regulatory agility can respond more rapidly to policy changes and emergent clinical needs. The convergence of clinical software and connected devices opens opportunities for new commercial models, including subscription-based service offerings that align revenue with device uptime and performance. Given these dynamics, firms that balance R&D investment in smart device capabilities with disciplined commercial execution and robust post-sale support will be best positioned to capture durable customer relationships and to expand into adjacent care settings.

Practical strategic priorities for manufacturers and providers to enhance device interoperability, supply resilience, sustainability, and service models that align commercial incentives with clinical outcomes

Industry leaders should adopt a multi-pronged strategy that aligns product development, commercial models, and operational resilience with evolving clinical and procurement expectations. Prioritize investments in interoperability standards and user-centered design to ensure that pumps and accessories integrate seamlessly into electronic health records and clinical workflows, thereby reducing alarm fatigue and improving adherence to infusion protocols. Simultaneously, diversify sourcing and qualify regional suppliers to reduce exposure to trade policy volatility, while developing contractual terms that support inventory visibility and rapid replenishment. Embedding robust training and remote support capabilities into commercial offerings will enhance user confidence, particularly in ambulatory and home-care contexts where clinical oversight is distributed.

Leaders should also evaluate sustainability and material substitution as strategic differentiators, exploring transitions away from legacy plastics where clinically and regulatorily feasible. Consider novel service models that shift part of the value proposition from unit sales to outcome-based contracts or managed device services, aligning incentives across providers and suppliers. Finally, cultivate cross-functional engagement between clinical engineering, procurement, and product teams to accelerate adoption of clinically validated alternatives and to ensure procurement decisions reflect both safety imperatives and long-term cost dynamics. These measures collectively strengthen competitive position and enable organizations to respond nimbly to regulatory and market shifts.

Methodological transparency describing a triangulated research approach that integrates clinician interviews, regulatory review, technical specification analysis, and supply chain scenario testing

This research synthesizes insights from a mixed-methods approach combining qualitative stakeholder interviews, technical literature review, regulatory analysis, and supply chain mapping to triangulate findings. Primary inputs included structured conversations with clinicians across acute, ambulatory, and home settings, procurement leaders, clinical engineers, and manufacturing executives to capture real-world decision criteria and operational constraints. Secondary sources encompassed device guidance from regulatory authorities, peer-reviewed clinical studies, and manufacturer technical specifications to validate performance claims and safety considerations.

Analytical methods involved cross-validating interview themes with documented policies and device specifications, and constructing scenario-based assessments to stress-test supplier resilience and product fit across diverse care pathways. Limitations of the methodology include potential variability in regional regulatory interpretation and the pace of technological adoption in specific clinical niches. To mitigate these factors, findings were subjected to iterative validation with independent clinical advisors and procurement specialists to ensure relevance and practical applicability for decision-makers seeking actionable intelligence.

Summative perspective emphasizing the need to integrate device intelligence, supply reliability, and sustainable practices into long-term intravenous equipment strategies

In conclusion, intravenous equipment strategy is now a multidimensional challenge that extends beyond device performance to encompass connectivity, supply chain resilience, and environmental stewardship. Clinicians and procurement leaders face competing priorities: ensuring patient safety and precision of delivery while managing total cost and operational continuity. The most successful market participants will be those that harmonize product innovation with practical service offerings and transparent supply strategies, enabling providers to meet the demands of shifting care models without compromising safety or accessibility.

Decision-makers should view current market dynamics as an opportunity to rearchitect relationships across the value chain, privileging partners who demonstrate both clinical empathy and operational reliability. By aligning procurement criteria with long-term device stewardship and by adopting service-oriented commercial models, stakeholders can reduce friction in device adoption and create pathways for sustained improvement in infusion safety and patient experience.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Intravenous Equipment Market, by Product Type

  • 8.1. Accessories
    • 8.1.1. Drip Chambers
    • 8.1.2. Extension Tubing
    • 8.1.3. Filters
    • 8.1.4. Infusion Sets
  • 8.2. Cannula
    • 8.2.1. Non Winged
    • 8.2.2. Winged
  • 8.3. Catheters
    • 8.3.1. Central
    • 8.3.2. Peripheral
    • 8.3.3. Peripherally Inserted Central
  • 8.4. Infusion Pumps
    • 8.4.1. Elastomeric Pumps
    • 8.4.2. Insulin Pumps
    • 8.4.3. Syringe Pumps
    • 8.4.4. Volumetric Pumps

9. Intravenous Equipment Market, by Material Type

  • 9.1. Polyolefin
  • 9.2. Polyurethane
  • 9.3. Polyvinyl Chloride

10. Intravenous Equipment Market, by Portability

  • 10.1. Portable
  • 10.2. Stationary

11. Intravenous Equipment Market, by Application

  • 11.1. Anesthesia
  • 11.2. Critical Care
  • 11.3. Nutrition Therapy
  • 11.4. Oncology
  • 11.5. Pain Management

12. Intravenous Equipment Market, by End User

  • 12.1. Ambulatory Care
    • 12.1.1. Clinics
    • 12.1.2. Diagnostic Centers
  • 12.2. Home Healthcare
  • 12.3. Hospital
    • 12.3.1. General
    • 12.3.2. Specialty Clinics

13. Intravenous Equipment Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Intravenous Equipment Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Intravenous Equipment Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States Intravenous Equipment Market

17. China Intravenous Equipment Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Abcam Inc.
  • 18.6. Advin Health Care
  • 18.7. Angel Electronic Equipment Co., Ltd.
  • 18.8. Argon Medical Devices, Inc.
  • 18.9. B. Braun SE
  • 18.10. Baxter International, Inc.
  • 18.11. Becton, Dickinson and Company
  • 18.12. Boston Scientific Corporation
  • 18.13. Cardinal Health, Inc.
  • 18.14. CODAN ARGUS AG
  • 18.15. Cook Group Incorporated
  • 18.16. Freudenberg Medical, LLC
  • 18.17. Henry Schein, Inc.
  • 18.18. ICU Medical, Inc
  • 18.19. Ivenix Inc.
  • 18.20. Merck KGaA
  • 18.21. Novo Nordisk A/S
  • 18.22. Pfizer Inc.
  • 18.23. QIAGEN
  • 18.24. Siemens AG
  • 18.25. Smith & Nephew PLC
  • 18.26. Stryker Corporation
  • 18.27. Teleflex Incorporated.
  • 18.28. Terumo Corporation
  • 18.29. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL INTRAVENOUS EQUIPMENT MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL INTRAVENOUS EQUIPMENT MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES INTRAVENOUS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA INTRAVENOUS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DRIP CHAMBERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DRIP CHAMBERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DRIP CHAMBERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY EXTENSION TUBING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY EXTENSION TUBING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY EXTENSION TUBING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY FILTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY FILTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY FILTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION SETS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION SETS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION SETS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NON WINGED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NON WINGED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NON WINGED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY WINGED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY WINGED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY WINGED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CENTRAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CENTRAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CENTRAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PERIPHERALLY INSERTED CENTRAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ELASTOMERIC PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ELASTOMERIC PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ELASTOMERIC PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INSULIN PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INSULIN PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY INSULIN PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SYRINGE PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SYRINGE PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SYRINGE PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY VOLUMETRIC PUMPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY VOLUMETRIC PUMPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY VOLUMETRIC PUMPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYOLEFIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYOLEFIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYOLEFIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYURETHANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYURETHANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYURETHANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYVINYL CHLORIDE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYVINYL CHLORIDE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY POLYVINYL CHLORIDE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY STATIONARY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY STATIONARY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY STATIONARY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ANESTHESIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ANESTHESIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ANESTHESIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CRITICAL CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CRITICAL CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CRITICAL CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NUTRITION THERAPY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NUTRITION THERAPY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY NUTRITION THERAPY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY ONCOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PAIN MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY PAIN MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOME HEALTHCARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOME HEALTHCARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY GENERAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY GENERAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY GENERAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 120. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 121. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 122. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 124. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 127. AMERICAS INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 131. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 132. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 133. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 134. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 136. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 137. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 138. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 145. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 146. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 148. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 151. LATIN AMERICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 200. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 225. GCC INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 226. GCC INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. GCC INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 228. GCC INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 229. GCC INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 230. GCC INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 231. GCC INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. GCC INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 233. GCC INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 234. GCC INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 235. GCC INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 236. GCC INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 237. EUROPEAN UNION INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPEAN UNION INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 249. BRICS INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. BRICS INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. BRICS INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 259. BRICS INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 261. G7 INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 262. G7 INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. G7 INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 264. G7 INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 265. G7 INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 266. G7 INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 267. G7 INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 268. G7 INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 269. G7 INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 270. G7 INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 271. G7 INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 272. G7 INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 273. NATO INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 274. NATO INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. NATO INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 276. NATO INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 277. NATO INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 278. NATO INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 279. NATO INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. NATO INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 281. NATO INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 282. NATO INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 283. NATO INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 284. NATO INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 285. GLOBAL INTRAVENOUS EQUIPMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 286. UNITED STATES INTRAVENOUS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 287. UNITED STATES INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 288. UNITED STATES INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 289. UNITED STATES INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 290. UNITED STATES INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 291. UNITED STATES INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 292. UNITED STATES INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 293. UNITED STATES INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 294. UNITED STATES INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 295. UNITED STATES INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 296. UNITED STATES INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 297. UNITED STATES INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)
  • TABLE 298. CHINA INTRAVENOUS EQUIPMENT MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 299. CHINA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 300. CHINA INTRAVENOUS EQUIPMENT MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 301. CHINA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CANNULA, 2018-2032 (USD MILLION)
  • TABLE 302. CHINA INTRAVENOUS EQUIPMENT MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 303. CHINA INTRAVENOUS EQUIPMENT MARKET SIZE, BY INFUSION PUMPS, 2018-2032 (USD MILLION)
  • TABLE 304. CHINA INTRAVENOUS EQUIPMENT MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 305. CHINA INTRAVENOUS EQUIPMENT MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 306. CHINA INTRAVENOUS EQUIPMENT MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 307. CHINA INTRAVENOUS EQUIPMENT MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 308. CHINA INTRAVENOUS EQUIPMENT MARKET SIZE, BY AMBULATORY CARE, 2018-2032 (USD MILLION)
  • TABLE 309. CHINA INTRAVENOUS EQUIPMENT MARKET SIZE, BY HOSPITAL, 2018-2032 (USD MILLION)